Legend Biotech · 1 month ago
Commercial Marketing Co-Op
Legend Biotech is a global biotechnology company dedicated to treating life-threatening diseases. They are seeking a Commercial Marketing Co-Op to support US Marketing, Market Access, and Operations projects, providing exposure to pharmaceutical marketing strategies and project management.
BiotechnologyHealth CareLife ScienceOncologyTherapeutics
Responsibilities
Assist in executing marketing and market access initiatives
Support operations projects and alliance activities
Prepare presentations, reports, and dashboards for internal stakeholders
Collaborate with cross-functional teams to ensure timely project delivery
Conduct market research and competitive analysis as needed
Qualification
Required
Enrolled in an accredited undergraduate or graduate program; returning to school after the internship or co-op
Minimum cumulative GPA of 3.5 on a 4.0 scale
Proficiency in Microsoft Office Suite (Word, Excel, PowerPoint, Outlook)
Strong written and verbal communication skills
Demonstrated ability to work collaboratively in team environments
Initiative, problem-solving ability, and eagerness to learn
Preferred
Preferred Majors: Business or healthcare-related fields
Desired Academic Grade Level: Graduate Student
Benefits
Medical, dental, and vision insurance
401(k)-retirement plan with company match that vest fully on day one
Equity and stock options
Eight weeks of paid parental leave after just three months of employment
Paid time off policy that includes 15 vacation days, 5 personal days, 5 sick days, 11 U.S. national holidays, and 3 floating holidays
Flexible spending and health savings accounts
Life and AD&D insurance
Short- and long-term disability coverage
Legal assistance
Supplemental plans such as pet, critical illness, accident, and hospital indemnity insurance
Commuter benefits
Family planning and care resources
Well-being initiatives
Peer-to-peer recognition programs
Company
Legend Biotech
Legend Biotech is a biopharmaceutical company that develops and commercializes novel cell therapies for oncology.
Funding
Current Stage
Public CompanyTotal Funding
$750.45M2023-05-05Post Ipo Equity· $350M
2022-07-25Post Ipo Equity· $250M
2020-06-05IPO
Recent News
legacy.thefly.com
2026-01-22
2026-01-22
Company data provided by crunchbase